ECP-treated lymphocytes of chronic graft-versus-host disease patients undergo apoptosis which involves both the Fas/FasL system and the Bcl-2 protein family

Archives of Dermatological Research

Volumn 295, Issue 5, 2003, Pages 175-182

  Di Renzo, M ^a,b   Rubegni, P ^a   Sbano, P ^a   Cuccia, A ^a   Castagnini, C ^a   Pompella, G ^a   Pasqui, A L ^a   Capecchi, P L ^a   Auteri, A ^a   Pasini, F Laghi ^a   Fimiani, M ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY HOSPITAL OF SIENA   (Italy)

Author keywords

Apoptosis; Cytokines; Extracorporeal photochemotherapy; Graft versus host disease

Indexed keywords

DNA FRAGMENT; FAS ANTIGEN; HISTONE; INTERLEUKIN 2; LIPOCORTIN 5; MESSENGER RNA; METHOXSALEN; PROTEIN BAX; PROTEIN BCL 2; TUMOR NECROSIS FACTOR ALPHA;

ADULT; APOPTOSIS; ARTICLE; CELL ISOLATION; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; INFUSION; LYMPHOCYTE; LYMPHOCYTE CULTURE; MALE; PHOTOCHEMOTHERAPY; PRIORITY JOURNAL; PROTEIN SYNTHESIS; ULTRAVIOLET A RADIATION; UPREGULATION;

ADULT; ANTIGENS, CD95; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BONE MARROW TRANSPLANTATION; CELLS, CULTURED; CHRONIC DISEASE; DOWN-REGULATION; FAS LIGAND PROTEIN; FEMALE; GENE EXPRESSION; GRAFT VS HOST DISEASE; HUMANS; INTERLEUKIN-2; LYMPHOCYTES; MALE; MEMBRANE GLYCOPROTEINS; PHOTOPHERESIS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 12444339731     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00403-003-0415-6     Document Type: Article

References (33)

1. Klingebiel T, Schlegel PG (1998) GVHD: overview on pathophysiology, incidence, clinical and biological features. Bone Marrow Transplant 21:S45-459
2. Ratanatharathorn V, Ayash L, Lazarus HM, Fu J, Uberti JP (2001) Chronic graft-versus-host disease: clinical manifestation and therapy. Bone Marrow Transplant 28:121-129
3. Lazarus HM, Rowe JM (1995) New and experimental therapies for treating graft-versus-host disease. Blood Rev 9:117-133
4. Russell-Jones R (1998) Extracorporeal photopheresis in chronic cutaneous graft-versus-host disease. Bone Marrow Transplant 22:612-613
5. Child FJ, Ratnavel R, Watchins P (1999) Extracorporeal photopheresis in the treatment of chronic GVHD. Bone Marrow Transpl 23:881-887
6. Bladon J, Taylor PC (2002) Extracorporeal photopheresis in cutaneous T-cell lymphoma and graft-versus-host disease induces both immediate and progressive apoptotic processes. Br J Haematol 146:59-68
7. Tambur AR, Ortegel JW, Morales A, Klingemann H, Gebel HM, Tharp MD (2000) Extracorporeal photopheresis induces lymphocyte but not monocyte apoptosis. Transplant Proc 32:747-748
8. Abbas A (1996) Die and let live: eliminating dangerous lymphocytes. Cell 84:655-657
9. Lynch DH, Ramsdell F, Anderson MR (1995) Fas and FasL in homeostatic regulation of immune response. Immunol Today 16:569-574
10. Boise Lh, Gottshalk AR, Quintans J, Thompson CB (1995) Bcl-2 and Bcl-2 related proteins in apoptosis regulation. Curr Top Microbiol Immunol 200:107-121
11. Hunter JJ, Parlow TG (1996) A peptide sequence from bax that converts bcl-2 into an activator of apoptosis, J Biol Chem 271:8521-8524
12. Ware CF, Van Arsdale S, VanArsdale TL (1996) Apoptosis mediated by the TNF-related cytokine and receptor families. J Cell Biochem 60:47-55
13. Edelson RL, Berger C, Gasparro F, Jegasothy B, et al (1987) Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. N Engl J Med 316:297-303
14. Wolfe JT, Lessin SR, Singh AH, Rook AH (1994) Review of immunomodulation by photopheresis: treatment of cutaneous T-cell lymphoma, autoimmune disease and allograft rejection. Artif Organs 18:888-897
15. Marks DI, Fox RM (1991) Mechanisms of photochemotherapy-induced apoptotic cell death in lymphoid cells. Biochem Cell Biol 69:754-760
16. Miracco C, Rubegni P, De Aloe G, D'Ascenzo G, Mazzatenta C, De Santi M, Fimiani M (1997) Extracorporeal photochemotherapy induces apoptosis of infiltrating lymphoid cells in patients with mycosis fungoides in early stages: a quantitative histological study. Br J Dermatol 137:549-557
17. Efferth T, Fabry U, Osieka R (2001) Induction of apoptosis, depletion of glutathione and DNA damage by extracorporeal photochemotherapy and psoralen with exposure to UV light in vitro. Anticancer Res 21:2777-2784
18. Bladon J, Taylor PC (1999) Extracorporeal photopheresis induces apoptosis in the lymphocytes of cutaneous T-cell lymphoma and graft-versus-host disease patients. Br J Haematol 107:707-711
19. Verms I, Haanen C, Steffens-Nakken H, Reutelingsperger C (1995) A novel assay for apoptosis: flow cytometry detection of phosphatidylserine expression on early apoptotic cell using fluorescein labeled Annexin V. J Immunol Methods 184:39-51
20. Vowels BR, Yoo EK, Gasparro FP (1996) Kinetic analysis of apoptosis induction in human cell lines by UVA and 8-MOP. Photochem Photobiol 63:572-576
21. Fadok VA, Voelker DR, Campbell PA, et al (1992) Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 148:2207-2216
22. Yoo EK, Rook AH, Elenitsas R, et al (1996) Apoptosis induction by ultraviolet light A and photochemotherapy in cutaneous T-cell lymphoma: relevance to mechanism of therapeutic action. J Invest Dermatol 107:235-242
23. Lenardo M, Chan FK, Hornung F, McFarland H, Siegel R, Wang J, Zheng L (1999) Mature T lymphocyte apoptosis. Annu Rev Immunol 17:221-253
24. Olivai ZN, Milliman CL, Korsmeyer SJ (1993) Bcl-2 heterodimerize in vivo with a conserved homolog, bax, that accelerates programmed cell death. Cell 74:609-619
25. Wang Y, Rosenstein B, Goldwyn S, Zhang X, Lebwohl M, Wei H (1998) Differential regulation of p53 and Bcl-2 expression by ultraviolet A and B. J Invest Dermatol 111:380-384
26. Bladon J, Taylor PC (2002) Lymphocytes treated by extracorporeal photopheresis demonstrate a drop in the Bcl-2/bax ratio: a possible mechanism involved in extracorporeal-photopheresis-induced apoptosis. Dermatology 204:104-107
27. Akbar AN, Borthwick NJ, Wickremasinghe RG, et al (1996) Interleukin-2 receptor common gamma-chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: selective induction of anti-apoptotic (bcl-2, bcl-xl) but not pro-apoptotic (bax, bcl-xS) gene expression. Eur J Immunol 26:294-299
28. Aringer M, Graninger WB, Smolen JS, Kiener HP, Steiner CW, Trautinger F, Knobler R (1997) Photopheresis treatment enhances CD95 (Fas) expression in circulating lymphocytes of patients with systemic sclerosis and induces apoptosis. Br J Rheumatol 36:1276-1282
29. Morita A, Werfel T, Stege H, Ahrens C, Karmann K, Grewe M, et al (1997) Evidence that single oxygen-induced human T helper cell apoptosis is the basic mechanism of ultraviolet-A radiation phototherapy. J Exp Med 186:1763-1768
30. Vowels BR, Cassin M, Boufal MH, Walsh LJ, Rook AH (1992) Extracorporeal photochemotherapy induces the production of tumour necrosis factor-a from monocytes: implications for the treatment of cutaneous T-cell lymphoma and systemic sclerosis. J Invest Dermatol 98:686-692
31. Voll RE, Herrmann M, Roth EA, Stach C, Kalden JR (1997) Immunosuppressive effects of apoptotic cells. Nature 390:350-351
32. Sun EW, Shi YF (2001) Apoptosis: the quiet death silences the immune system. Pharmacol Ther 92:135-145
33. Snyder EL, Kuter DJ (2000) Apoptosis in transfusion medicine: of death and dying - is that all there is? Transfusion 40:135-138